-
The company offers test for markers for cancer treatment for both lung and colon cancer to help determine which treatment plans will benefit the patient. The use of genetic testing is getting very specific as well as the tests and expressions. “RGI has determined ranges of ERCC1 expression...
-
The drug, ATryn has already been approved in Europe. Up until now the drug has been created from blood from human donors. The drug is used to prevent blood clots and would be used during surgery given via an IV, and would not replace normal prescribed blood thinners taken as a normal treatment...
-
Will Plavix be the next drug up for a genetic test? There are not many alternative drugs either that could easily replace the functionality of Plavix, it is a blood thinner. One idea would be to monitor patients with poor liver or kidney metabolization. as suggested here , a blog written...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-02-2009
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, Physician, personalized medicine, DNA, Genomics, healthcare, Health IT, Cardiology, Biotech, FDA, Information Overload, Pharmacogenomics, Sequencing, FDA warnings, Plavix
-
This is a very good point, getting all the data organized into a fashion where it can be used and analyzed. Back a few months ago when I interviewed Patrice Milos, Vice President and Chief Scientific Officer, of Helicos BioSciences I asked the same question, and also if each interpretation would...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-22-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, DNA, Genomics, healthcare, microsoft, Health IT, Biotech, Pharmacogenomics, Helicos, Sequencing
-
Amish Country is probably the last place one would think of genomic R and D activity, but not so. Here’s a post from July of 2008. The original study focused on locating deadly genetic diseases, but out of the study came a mutation that could lead to development of new types of medications...
-
I try to cover quite a bit on the blog relative to personalized medicine and how it links and will connect to the clinical side of healthcare. Navigenics has always had the focus on working with the physicians versus the commercial direct sale to the consumer. MDVIP, Inc. is a privately-held firm...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-08-2008
Filed under:
Filed under: Medically Related, Technology, personalized medicine, DNA, Genomics, Medical Records, EHR, PHR, Heatlhcare, Navigenics, genetic counselors, gentic testing
-
This is pretty controversial in essence, if you have ever watched parent already getting pretty steamed up at baseball and soccer games, so next we could easily have some heated discussions on how long each child can play with parents feuding over who’s child has the best gene in the bunch and who would...
-
One of the founds is no other than James Thomson, an early stem cell pioneer, and the company just raised a few million more with investors, so all biomed is not in the same situation, I think it depends largely on what area of biomed is the focus. So in the future, maybe donate some DNA, grown...
-
Let’s put it another way, it can’t exist without IT. Again it all comes back to running algorithms to obtain desired results. As I have mentioned before, Algorithms is one of the hottest words right now in healthcare as we all make decisions from queried results. A while back I had the opportunity...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-25-2008
Filed under:
Filed under: Medically Related, Technology, Microsoft/Windows News, EMR, personalized medicine, DNA, Genomics, healthcare, microsoft, Medical Records, EHR, Health IT, Biotech, Pharmacogenomics, Helicos, Sequencing
-
The manufacturers of the machines that run our DNA are still very much in the forefront, gaining investors with DNA sequencing. BD NEW YORK (GenomeWeb News) – Menlo Park, Calif.-based Pacific Biosciences today said that it recently received $20 million in funding from new investor Blackstone Cleantech...
-
It should be the discretion of individual physicians, not insurance companies or pharmacies, to substitute a branded biologic for a biosimilar, which goes back to putting the physician in the decision making process, not the non clinical analyzers. While the search for "cheap" continues...
-
Dentists now are coming in to the fold of DNA genomics tests. This test is very specific to assess risk for periodontal disease, so as a younger patient, as chances are as we age if we are at risk we may already have this, this could be a good indicator for the dentist to have in the knowledge...
-
After all the recent news about the PSA test, here's a genomics answer. The MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells. The new prostate cancer test will be performed at Clarient's Clinical...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-07-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, personalized medicine, DNA, Genomics, Prostate Cancer, Pharmacogenomics, PSA, Cancer Test
-
The software offers both detailed, localized views of genomic data, and a whole genome view, in a format somewhat similar to the way Google presents items on the web. It is free to download and use. There are also some sample data files available. I like the idea of the heat map view...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-06-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, DNA, Genomics, Research, Pharmacogenomics, MIT, Biomed, Broad Institute, Harvard
-
The program uses just plain old Java, but add this technology with sequencing information and with the 4D applications, studies can be virtually conducted to see how a medication would react with selected settings. Its resolution is scaleable to 100,000,000 pixels and more by using more than one...